Olema Pharmaceuticals Inc... (OLMA)
5.31
0.17 (3.31%)
At close: Jan 15, 2025, 11:14 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 377.00K | 1.66M | 1.66M | 11.00K | 9.03K | 8.24K |
| Gross Profit | -377.00K | -1.66M | -1.66M | -11.00K | -9.03K | -8.24K |
| Operating Income | -104.96M | -106.99M | -71.49M | -21.53M | -4.32M | -2.08M |
| Interest Income | 8.32M | 2.23M | 442.00K | 60.00K | 7.00K | 4.00K |
| Pretax Income | -96.66M | -104.79M | -71.10M | -22.12M | -4.32M | -2.20M |
| Net Income | -96.66M | -102.59M | -70.89M | -22.76M | -4.32M | -2.20M |
| Selling & General & Admin | 18.82M | 24.71M | 20.39M | 7.82M | 403.00K | 386.00K |
| Research & Development | 86.14M | 82.27M | 51.10M | 13.70M | 3.92M | 1.69M |
| Other Expenses | n/a | -27.00K | -47.00K | n/a | n/a | -31.00K |
| Operating Expenses | 104.96M | 106.99M | 71.49M | 21.53M | 4.32M | 2.08M |
| Interest Expense | n/a | n/a | n/a | 653.00K | n/a | 28.00K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 104.96M | 106.99M | 71.49M | 21.53M | 4.32M | 2.08M |
| Income Tax | n/a | -2.20M | -210.00K | 642.00K | -155.86K | -90.00K |
| Shares Outstanding (Basic) | 45.25M | 40.00M | 39.52M | 39.31M | 40.17M | 14.10M |
| Shares Outstanding (Diluted) | 45.25M | 40.00M | 39.52M | 39.31M | 40.17M | 14.10M |
| EPS (Basic) | -2.14 | -2.56 | -1.79 | -0.58 | -0.11 | -0.16 |
| EPS (Diluted) | -2.14 | -2.56 | -1.79 | -0.58 | -0.11 | -0.16 |
| EBITDA | -104.58M | -103.13M | -69.43M | -21.52M | -4.31M | -2.16M |
| Depreciation & Amortization | 377.00K | 1.66M | 1.66M | 11.00K | 9.03K | 8.24K |